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Summary
Nine affected individuals are described from a large ex-
tended Pakistani family manifesting a syndrome char-
acterized by a triad of varying degrees of spasticity, se-
vere mental retardation, and visual impairment resulting
from tapetoretinal degeneration. In all cases, the parents
were at least first cousins, since there was complex con-
sanguinity within the pedigree. The clinical features dif-
fer from previously reported syndromes involving pig-
mentary retinal degeneration and appear to represent a
new recessively inherited neurodegenerative condition.
Linkage to a 4–5 cM-region between markers D15S211
and D15S152 on 15q24 has been established by autozy-
gosity mapping.
Introduction
Pigmentary retinopathy or tapetoretinal degeneration
can be a feature of a number of inherited metabolic
disorders and syndromes of unknown etiology. The clas-
sification depends on the constellation of clinical features
and metabolic abnormalities seen in the affected indi-
viduals (table 1). Some of the syndromes with an un-
known etiology have overlapping features (Norio and
Raitta 1986), and it is only when the molecular etiology
is known that a comprehensive classification system will
be realized. We report a family that has some of the
features described in other case reports of syndromes
involving retinal pigmentation/degeneration. However,
many of the features reported elsewhere are absent, and
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we propose that this condition represents a new clinical
disorder.
The possibility of using consanguineous families to
map rare recessive disorders was first published in 1953
(Smith 1953). This concept was expanded in 1987
(Lander and Botstein 1987), but, with the advent of large
numbers of highly polymorphic markers, autozygosity
mapping only recently has started to fulfil its potential.
It has been used to map rare recessive syndromes (Ben
Hamida et al. 1993) as well as highly heterogeneous
common conditions (Petit 1996). This technique has
been utilized in mapping this previously unreported dis-
order to chromosome 15q24.
We report a family with nine cases, from four related
sibships, presenting with a syndrome that is character-
ized by spasticity of varying degrees, severe mental re-
tardation, and progressive visual impairment caused by
a tapetoretinal degeneration. Some affected individuals
showed dystonic features, but no additional neurological
features or other associated abnormalities were noted by
clinical examination. The clinical picture differs from
previously described syndromes involving a tapeto-
retinal degeneration and may represent a previously un-
recognized neurodegenerative disorder. The parental
consanguinity and pattern of inheritance within the ped-
igree make autosomal recessive inheritance likely. Au-
tozygosity mapping was used to establish linkage of this
family to chromosome 15q24, following a genomewide
search using highly polymorphic microsatellite markers.
Subjects and Methods
Subjects
The nine affected individuals are from four related
sibships from two generations of a large consanguineous
family originating from the Mirpur district of northern
Pakistan. There was a high degree of consanguinity
within the family (fig. 1).
Sibship 1.—Four affected individuals (VI-1, VI-2, VI-
3, and VI-5) were identified. All presented with global
developmental delay and visual impairment at 9–12 mo
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Table 1
Disorders in Which Pigmentary Retinopathy Is a Feature
Inherited Metabolic Disorder or
Syndrome Associated with
Pigmentary Retinopathy MIM No(s). Reference(s)
Metabolic disorder:
Abetalipoproteinaemia (Bassen-Kornzweig) 200100 Bassen and Kornzweig (1950)
Refsum disease 266500 Refsum (1952)
Infantile Refsum disease 266510 Scotto et al. (1982)
Neuronal ceroid lipofuscinosis (Batten disease) 204200 Wisniewski et al. (1992)
Mucopolysaccharidosis type II (Hunter disease) 309900 Gerich (1969)
Mucolipidosis type IV 252650 Amir et al. (1987)
Peroxisomal disorders ) Moser et al. (1995)
Syndrome:
Laurence-Moon-Biedl-Bardet syndrome 245800
209900
Bardet (1920)
Laurence et al. (1866)
Usher syndrome 276900 Hallgren (1959)
Cockayne syndrome 216400 Cockayne (1933)
Alstrom syndrome 203800 Alstrom et al. (1959)
Joubert syndrome 213300 Joubert et al. (1969)
Jeune syndrome 208500 Allen et al. (1979)
Hallervorden-Spatz disease 234200 Hallervorden and Spatz (1922)
Senior-Loken syndrome 266900 Senior et al. (1961)
Boucher-Neuhauser syndrome 215470 Boucher and Gibberd (1969)
Leber amaurosis 204000 Leber (1871)
Cohen syndrome 216550 Cohen et al. (1973)
Mirhosseini-Holmes-Walton syndrome 268050 Mirhosseini et al. (1972)
of age. At the time of examination, ages were 12–17
years, and all showed severe mental retardation. Clinical
examination revealed spasticity affecting all four limbs
of the oldest three individuals. The youngest (individual
VI-5) showed marked muscle wasting but no spasticity.
All four were microcephalic, but head circumferences
within the normal range had been documented at birth.
All showed a retinal dystrophy with marked attenuation
of retinal arterioles and secondary optic atrophy. No
other dysmorphic features or abnormalities were noted
by clinical examination, apart from wide-spaced teeth
and a single palmar crease, in all four individuals
Sibship 2.—The affected individual (V-3) presented
with global developmental delay and poor vision, which
was apparent from 2 years of age. When seen at 23 years
of age, she showed a marked spastic paraplegia with
dystonic posturing and severe mental retardation. Oph-
thalmological examination showed mild optic atrophy
with gross attenuation of retinal arterioles and subtle
retinal pigmentation. Clinical examination was other-
wise normal. Two siblings (V-4 and V-6) showed mild
developmental delay but no physical abnormalities, and
one additional sibling (V-8) was diagnosed with con-
genital stationary night blindness and mild learning dif-
ficulties. He showed no features of spasticity, and, after
expert ophthalmic review, he was not considered to dem-
onstrate the same retinal dystrophy as his sister.
Sibship 3.—Two affected individuals (V-9 and V-13)
were identified. Both presented with global develop-
mental delay and poor vision within the first 18 mo of
life, having appeared normal during early infancy.When
seen at 29 and 20 years of age, respectively, both indi-
viduals showed a marked spastic quadriplegia, with dys-
tonic posturing evident in individual V-13. Both were
severely mentally retarded. Ophthalmological exami-
nation showed a severe tapetoretinal degeneration with
gross optic atrophy in individuals V-9 and V-13.
Sibship 4.—Two affected individuals (V-14 and V-15)
were identified. Both presented within the first 18 mo
of life, with global developmental delay and poor vision.
When seen at 24 and 22 years of age, respectively, both
showed generalized hyperreflexia with dystonic postur-
ing noted and severe mental retardation. Individual V-
15 also showed spasticity affecting the lower limbs and
was microcephalic. Ophthalmological examination of
individual V-14 showed optic atrophy with marked at-
tenuation of retinal arterioles. Mild retinal pigmentation
was noted in individual V-15. General examination was
otherwise normal.
Families
Affected individuals were visited and clinically ex-
amined at home. Ten milliliters of venous blood was
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Figure 1 Genotype data for markers (ordered cen–tel) from the region of linkage on chromosome 15q24
collected from all consenting individuals. DNA was ex-
tracted by use of standard protocols.
Clinical Investigations
The following clinical investigations were carried out:
blood and urinary amino acids, normal; urinary organic
acids, normal; white-cell enzymes (hexosaminidase, b-
galactosidase, and aryl sulphatase), normal; blood film,
no white-blood-cell inclusion bodies; and skin biopsy,
electron microscopy normal. Because of the close phe-
notypic similarities seen, investigations were not dupli-
cated on all affected individuals. None of the affected
individuals had undergone cranial imaging at the time
of this study. All were severely mentally retarded and
would have required heavy sedation or even general an-
esthesia to facilitate this. It was felt that the risks to the
patients could not be justified when the information
yielded would be unlikely to influence clinical manage-
ment or genetic counseling.
Genotyping
A genomewide linkage analysis was performed by use
of a set of 254 polymorphic microsatellite markers with
an average spacing of 12–14 cM (Reed et al. 1994).
Extra markers from regions of interest were obtained
from the CEPH-Ge´ne´thon web site (http://www
.cephb.fr/bio/ceph-genethon-map.html). Oligonucleo-
tides were modified with a 5′ fluorescent label, for anal-
ysis by use of an automated ABI 377 gene scanner.
PCRs were performed in a total volume of 20 ml of
1# reaction buffer containing 40 ng of DNA, 0.2 mM
dNTPs, 1.5 mM MgCl2, 50 ng each primer, 1 unit Taq
DNA polymerase, 50 mM KCl, 10 mM Tris-HCl (pH
9.0), and 0.1% Triton X-100. Annealing temperatures
were optimized for each primer pair. PCRs were per-
formed as follows: initial denaturing at 95C/5 min, fol-
lowed by 30 cycles of 95C/20 s, annealing temperature/
20 s, and 72C/20 s. Products were analyzed on a
4%-polyacrylamide/6-M urea/1# Tris borate–EDTA
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Figure 2 Results of multipoint analysis for the region of linkage.
a, Entire family. b, Affecteds only. c, Sibships 1, 3, and 4.
gel for 2 h/3,000 V/51C. Data was captured and ana-
lyzed by use of the ABI Genescan Analysis software
package, and the genotypes were generated by use of
the Genotyper software package.
Multipoint analysis was performed by use of the
HOMOZ/MAPMAKER program (Kruglyak et al.
1995). The disease gene frequency was estimated to be
1/200. Marker allele frequencies for each of the markers
were assumed to be equal.
Results
All the affected individuals were analyzed with a total
of 254 highly polymorphic markers. One marker,
D15S114, was homozygous in six of the nine affected
individuals. Therefore, an additional eight extramarkers
from this region were identified, from the Ge´ne´thon
map, at spacings of ∼1–2 cM (cen–D15S1005,
D15S211, D15S1041, D15S206, D15S205, D15S152,
D15S1030, D15S116–tel), resulting in a total of nine
markers spanning a 15-cM region. The haplotypes gen-
erated are shown in figure 1.
Multipoint analysis was performed on each sibship of
the family by use of HOMOZ/MAPMAKER, and the
results were combined (fig. 2). The maximum LOD score
obtained by use of this analysis was 3.4. The LOD scores
generated from sibships 1, 3, and 4 were maximal for
the pedigree structure; summation of the results for these
branches of the family yielded a LOD score of 6.44
between D15S1041 and D15S205 (fig. 2).
Only one member of sibship 2 had the full phenotype
and was therefore classified as affected, for the initial
analysis. However, three other members of the family
had mild mental retardation, and one of these members
also had spasticity and night blindness but did not have
the unusual retinal dystrophy seen in the other affected
members of the family. These individuals initially were
coded as unaffected, for the analysis, but they may rep-
resent variable expression of the disease phenotype. In
order to circumvent this problem, an “affected-individ-
uals-only” analysis was performed, and this analysis
generated a maximum LOD score of 5.6 between
D15S211 and D15S152. In this sibship, all four indi-
viduals with some form of neurological abnormality
have the same haplotype at D15S1041–D15S205.
In general, the minimal critical region in autozygosity
mapping is the smallest region of autozygosity shared
by the affected individuals and not by the unaffected
individuals within the pedigree. In order to be confident
of the boundaries flanking the locus in this pedigree,
only the affected individuals may be used. The only re-
gion of autozygosity common to all the affected indi-
viduals is between marker D15S211 and D15S152, a
distance of ∼4 cM. A common haplotype for markers
D15S1041, D15S206, and D15S205 can be seen in all
the affected individuals (fig. 1).
We have demonstrated linkage of a novel develop-
mental syndrome to chromosome 15q24. This syndrome
consists of the unique triad of severe mental retardation,
an unusual pigmentary retinopathy, and varying degrees
of nonprogressive spasticity.
Discussion
Pigmentary retinopathy or tapetoretinal degeneration
is a feature of a number of genetic disorders (table 1).
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The normal metabolic investigations, the absence of spe-
cific associated abnormalities, and the phenotypic dif-
ferences in affected individuals distinguish the condition
described in this family from disorders described
elsewhere.
Reported cases of Mirhosseini-Holmes-Walton syn-
drome (MIM 268050) (Mirhosseini et al. 1972; Mendez
et al. 1985) show some features in common with the
cases described in this report, but these previously de-
scribed cases differ in the occurrence of cataracts, dys-
morphic facial appearances, truncal obesity, and joint
hypermobility and arachnodactyly. It subsequently has
been suggested that these cases may represent variants
of Cohen syndrome (MIM 216550) (Norio and Raitta
1986; Steinlein et al. 1991), with clear phenotypic dif-
ferences from the affected individuals in the family de-
scribed in this study.
A syndrome of hereditary spastic paraplegia with ret-
inal degeneration (MIM 270700) has been described
(Stewart 1937; Evans 1954; Mahloudji and Chuke
1968;MacRae et al. 1974), but adult onset was observed
in all cases. Hereditary spastic paraplegia with a pig-
mentary retinopathy and dementia (MIM 236130) was
described by Sjaastad et al. (1976); but, in that condi-
tion, the age at onset was 5–20 years, and the retinop-
athy differed from that in the family described here, pre-
senting with color blindness followed by the
development of diffuse retinal pigmentation. Raised lev-
els of homocarnosine were found in the cerebrospinal
fluid of affected patients.
The pigmentary retinopathy seen in the family de-
scribed herein is unique. Affected individuals appeared
normal at birth and during early infancy but presented
with global developmental delay, visual impairment re-
sulting from a tapetoretinal degeneration, and the de-
velopment of varying degrees of spasticity during the
first 18–24 mo of life. Dystonic features were seen in
some patients, but there were no other neurological ab-
normalities or associated features. There is evidence that
the disease follows a progressive course, with the older
individuals appearing to be more severely affected and
with, in some, the observed development of microceph-
aly during the first few years of life. Biochemical inves-
tigations have not identified an underlyingmetabolic dis-
order, and the affected individuals in this extended
family may be manifesting a previously undescribed neu-
rodegenerative condition.
By use of an affected-individuals-only analysis, the
disorder in this family has been mapped to a 4–5-cM
interval on chromosome 15q24, with a maximum LOD
score of 5.44 between markers D15S211 and D15S152.
In this family, 254 markers were genotyped at an average
spacing of 12–14 cM. Only one region was autozygous
for an interval 17 cM, in the affected members of the
first sibship. The affected members of sibships 3 and 4
also were autozygous for 110 cM of this region. Indi-
vidual V-3 in sibship 2 was homozygous for markers
D15S1041, D15S206, and D15S205 and was hetero-
zygous at both D15S211 and D15S152, giving a max-
imum autozygous region of ∼4–5 cM. The small autozy-
gous region seen in sibship 2 suggests that the
disease-causing mutation(s) occurred several generations
ago, which increases the likelihood that the disease allele
was inherited from one of the more distantly related
individuals “marrying into” the family in a recent
generation.
Although the degree of spasticity is variable across the
whole pedigree, the retinal dystrophy and mental retar-
dation are severe in all the affected members of sibships
1, 3, and 4. Sibship 2 is interesting in that it includes
one individual who has all of the severe features seen in
the other branches of the family and three additional
individuals who have either mild mental retardation or
mild mental retardation, spasticity, and night blindness.
Spasticity and mental retardation are often variable
within single sibships (Mitchell and Bundey 1997), and
retinopathies are also known to have variable pheno-
types. There are two plausible explanations for the data
seen in sibship 2. The most likely explanation is that
this is a variable condition and that the other members
of the sibship are showing a phenotype that is milder
than that shown by individual V-3. The clinical phe-
notypes were well documented prior to the genotyping
information being available. This would map the re-
sponsible gene(s) to the interval defined previously. A
second explanation is that the disease-causing mutation
lies between D15S205 and D15S152 and that a recom-
bination event has occurred between these two markers.
This would map the gene to a 1–2-cM region.
Rare familial disease phenotypes can be the result of
a permissive mutation within a highly conserved and
vital gene, small deletions affecting contiguous genes, or
separate mutations in two or more contiguous genes.We
have concentrated our search, for candidate genes, on
the retinal phenotype seen in this family. Two retinal
genes are known to map to this region: the gene for
cellular retinoic acid–binding protein (Eller et al. 1992)
and the gene for cellular retinaldehyde-binding protein
(Maw et al. 1997). The first of these genes is ubiquitously
expressed, with particularly high levels of expression in
retina and skin. The second gene is that for retinalde-
hyde-binding protein, which is expressed almost exclu-
sively within the retina, although an expressed sequence
tag (EST) has been sequenced from a hippocampal li-
brary with an identical 3′ UTR, suggesting that low-level
expression may be present elsewhere. Recently, a mu-
tation within this gene has been shown to be involved
in retinitis pigmentosa, but there were no associated fea-
tures within the family described (Maw et al. 1997).
Both of these genes are candidates for the disorder that
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we describe, although the expression pattern of the gene
for retinaldehyde-binding protein suggests that, if this
gene is responsible for the retinal disease, then a second
gene may well be responsible for the spasticity and men-
tal retardation. There also are five ESTs, expressed in
retinal libraries, that map to the critical region (Schuler
et al. 1996).
The mapping and subsequent cloning of genes in-
volved in rare recessive conditions will provide unique
information about both normal and abnormal devel-
opment in humans. Increased understanding of the nor-
mal developmental pathways within neuronal develop-
ment hopefully will lead to better treatment and
prognosis for patients suffering from a wide variety of
nonprogressive neurological conditions and neurode-
generative diseases. Visual impairment is a major hand-
icap, and a better understanding of retinal development
offers the hope of delaying and even reversing conditions
leading to retinal degeneration.
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